Clyde’s characterisation
and validation service
For new hiPSC cardiomyocyte providers, Clyde can offer the following characterisation and validation service
Optimising plating densities lines
Assess voltage, calcium and contractility baseline characteristics
Perform restitution curve
Test CiPA 8 reference compounds
Test CiPA 28 reference compounds
Run head to head comparison with leading hiPSC cardiomyocyte provider
Characterise diseased hiPSC cardiomyocyte cell lines
The characterisation will provide the client with a comprehensive data package for marketing collateral. More importantly, the data will validate the cardiomyocyte for inclusion into the CiPA assay for IND submissions.
Start a study with Clyde
To enquire about how Clyde could help with your project complete the enquiry form below and we’ll be get back to you as soon as we can. Alternatively email us at info@clydebio.com